Clinical Trial Update: The SIR-POBA Bypass Trial [NA]

View source ↗

Summary

The SIR-POBA Bypass Trial has been withdrawn, with no active status for the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb-threatening Ischemia
• Femoropopliteal Artery Occlusion
• Femoropopliteal Stenosis
• Intermittent Claudication
• Peripheral Arterial Occlusive Disease

Snippet

Sponsor: Paracelsus Medical University | Conditions: Peripheral Arterial Occlusive Disease, Bypass Complication | NA | Status: WITHDRAWN